A Pathologically Friendly Strategy for Determining the Organ-specific Spatial Tumor Microenvironment Topology in Lung

Xuqi Sun1, Xiao Teng2, Chuan Liu1

  • 1Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.

Insights

Lung cancer immunotherapy response varies by organ. This study reveals distinct immune cell landscapes in primary tumors and metastases, guiding tailored treatment strategies.

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Lung cancer exhibits heterogeneous organ-specific responses to immunotherapy.
  • Understanding the tumor microenvironment (TME) is crucial for deciphering these divergent responses.
  • Challenges in single-cell profiling of formalin-fixed paraffin-embedded (FFPE) materials hinder TME dissection.

Purpose of the Study:

  • To dissect the organ-specific cellular and spatial TME in lung adenocarcinoma (LUAD) using FFPE samples.
  • To reveal divergent immune niches and cellular neighborhoods across primary LUAD and its metastases.
  • To identify mechanisms underlying differential immunotherapy responses in LUAD.

Main Methods:

  • Single-cell nuclei RNA sequencing of 84,294 cells.
  • Imaging mass cytometry (IMC) on 250,600 cells.
  • Analysis of paired primary LUAD and metastatic FFPE samples.

Main Results:

  • Divergent organ-specific immune niches were identified.
  • Immunotherapy-responsive sites (primary LUAD, adrenal metastases) showed enrichment of B, plasma, and T cells.
  • Immunosuppressive sites (brain, liver metastases) displayed collagen I deposition and T cells expressing TIM-3.
  • Spatial proximity of B and CD4+ T cells was observed at immunogenic sites.
  • Organ-specific densities of tertiary lymphoid structures were detected.

Conclusions:

  • This study provides a comprehensive single-cell landscape of the organ-specific TME in LUAD at both cellular and spatial levels.
  • Findings highlight the necessity for organ-specific treatment approaches in lung adenocarcinoma.
  • The characterized TME features offer insights into immunotherapy resistance and response mechanisms.

Related Concept Videos